What Are Wall Street Analysts' Target Price for Abbott Stock? While Abbott has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · Nov 10
Edwards PASCAL Precision Wins FDA Approval as the Second Catheter Repair Option for Severely Leaking Tricuspid Valves The FDA approved Edwards' PASCAL Precision for catheter-based repair of severe tricuspid valve leaks in higher-risk patients. One-year trial data come at TCT. Medical Daily · Oct 24
Cologuard Is Working—So Why Isn’t Abbott Stock? Abbott's stock fell 4% despite solid Q3 results, as it trimmed full-year sales guidance and announced plans to spin off its Nutrition business into a separate public company by 2027. MarketBeat · Oct 22
Stocks Rally on Positive AI News, with SpaceX up +7% The S&P 500 Index ($SPX ) (SPY ) rose +0.59% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) rose +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +1.13%. December E-mini S&P futures (ESZ26 ) rose +0.62%, and December E-mini Nasdaq futures (NQZ26 ) rose... Barchart · Oct 21
Stocks See Support from Positive AI News, with SpaceX up +9% The S&P 500 Index ($SPX ) (SPY ) is up +0.22%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.70%. December E-mini S&P futures (ESZ26 ) are up +0.27%, and December E-mini Nasdaq futures (NQZ26... Barchart · Oct 21
Stocks See Support from Positive AI News The S&P 500 Index ($SPX ) (SPY ) is up +0.24%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.69%. December E-mini S&P futures (ESZ26 ) are up +0.15%, and December E-mini Nasdaq futures (NQZ26... Barchart · Oct 21
Three shares bought in 1935 grew into a $7 million gift for students Grace Groner lived a modest life in Lake Forest, Illinois, despite eventually accumulating a fortune worth more than $7 million. She never married or had children, worked for more than four decades as a secretary at Abbott Laboratories and remained closely connected to Lake Forest College, where she graduated in… The Times of India · Oct 5
A Tiny Pacemaker Flipped Upside Down Inside a Man's Heart, and It Took Two Snares to Pull It Out A replacement leadless pacemaker came loose and flipped into a man's ventricle. Doctors needed two snares to pull it out, then mapped a new site. Medical Daily · Oct 1
Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know Abbott Laboratories is set to report its third-quarter results coming month, with analysts expecting single-digit growth in earnings. Barchart · Oct 1
In 1935, Grace Groner, a secretary, invested $180 in her employer Abbott; 75 years later, it had grown to about $7 million Grace Groner made a $180 investment in Abbott Laboratories in 1935 while working as a secretary. She held onto the shares for about 75 years, allowing her investment to grow significantly. Upon her death in 2010, her estate was valued at approximately $7 million. Groner lived a modest lifestyle despite… The Economic Times · Sep 30
Teens on GLP-1 Drugs: 12.4% Diagnosed with Vitamin D Deficiency Within a Year, and Few Got Nutrition Counseling 12.4% of teens on GLP-1 drugs were diagnosed with vitamin D deficiency within a year. Questions parents can ask about bloodwork, diet, and supplements. Medical Daily · Sep 29
Abbott Agrees to Pay Nearly $385 Million Over Infant Formula Manufacturing Allegations Abbott Laboratories has agreed to pay nearly $385 million to settle federal and state allegations involving the manufacture of certain powder infant formula and nutritional therapy products, including products purchased through government-funded nutrition programs. Clever Dude · Sep 22
Beta Bionics Wins FDA Clearance for Mint Tubeless Insulin Patch Pump, Plans Pharmacy-Only U.S. Launch in Early 2027 The FDA cleared Beta Bionics' Mint tubeless insulin patch pump. What the clearance covers, when it launches, and what people with diabetes should know. Medical Daily · Sep 16
Abbott Agrees to Pay Nearly $385 Million to Settle Claims Over Infant Formula Made in Michigan and Arizona Abbott will pay $384,999,040 to settle False Claims Act allegations over infant formula from its Sturgis and Casa Grande plants. What parents should know. Medical Daily · Sep 16
The Times of India · Sep 14 Abbott agrees to pay nearly $385 million to US government over alleged infant formula false claims Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns. Abbott maintains that no distributed infant formula tested positive for Cronobacter and says government testing found…
The Independent UK · Sep 14 Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant Abbott closed the Sturgis facility in February 2022 following the start of an investigation by the FDA
Barchart · Sep 1 Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector? Despite Abbott Laboratories' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.
Medical Daily · Aug 26 Diabetes Wearable Cleared for Children as Young as Two Tracks Ketones and Blood Sugar from One Sensor The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking ketones and glucose together, for people with diabetes aged 2 and up.
Barchart · Aug 6 Abbott Stock: Is Wall Street Bullish or Bearish? Abbott has lagged behind the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.
The Independent UK · Aug 3 New blood test to detect colon cancer clears FDA approval New cases of colorectal cancer and deaths have been rising in younger adults since the mid-2000s
Medical Daily · Jul 30 FDA Approves a Blood Test for Colorectal Cancer Screening That Misses Most Precancerous Growths The FDA approved SimpleScreen CRC, a blood test for colorectal cancer screening. It detects cancer well but finds few precancerous lesions.
Barchart · Jul 20 This Dividend King Could Be One of the Safest Stocks to Own Right Now Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock.
International Business Times UK · Jul 20 Trump DOJ Drops Corporate Crime Investigations, Giving Major Companies a Free Pass The Trump Justice Department has dropped several high-profile corporate investigations, including an inquiry into Federal Reserve Chair Jerome Powell, fueling concerns over a pullback in enforcement.
MarketBeat · Jul 16 Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Abbott's Q2 results show solid organic growth, better-than-expected margins, and improved earnings guidance, easing concerns over the Exact Sciences acquisition and boosting ABT shares.
The Economic Times · Jul 16 Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.